翻訳と辞書
Words near each other
・ Ipaglaban Mo!
・ Ipai language
・ Ipak
・ Ipak verujem u sebe
・ Ipakly
・ Ipala
・ Ipala (Tanzanian ward)
・ Ipala, Bam
・ Ipala, Ganzourgou
・ Ipala, Guatemala
・ IPALG
・ Ipalibo Banigo
・ Ipalogama Divisional Secretariat
・ IPAM
・ Ipameri
Ipamorelin
・ Ipan
・ Ipan Priyanto
・ Ipana
・ Ipande
・ Ipande (Manyoni ward)
・ Ipanema
・ Ipanema (album)
・ Ipanema (disambiguation)
・ Ipanema Atlético Clube
・ Ipanema bat
・ Ipanema Hill
・ Ipanema River
・ Ipanema Technologies
・ Ipanema, Minas Gerais


Dictionary Lists
翻訳と辞書 辞書検索 [ 開発暫定版 ]
スポンサード リンク

Ipamorelin : ウィキペディア英語版
Ipamorelin

Ipamorelin (INN) (developmental code name NNC 26-0161) is a peptidic, selective agonist of the ghrelin/growth hormone secretagogue receptor (GHS) and a growth hormone secretagogue. It is a pentapeptide with the amino acid sequence Aib-His-D-2-Nal-D-Phe-Lys-NH2 that was derived from GHRP-1.
Ipamorelin significantly increases plasma growth hormone (GH) levels in both animals and humans.〔〔 In addition, ipamorelin stimulates body weight gain in animals.〔 Like pralmorelin and GHRP-6, ipamorelin does not affect prolactin, follicle-stimulating hormone (FSH), luteinizing hormone (LH), or thyroid-stimulating hormone (TSH) levels.〔 However, unlike pralmorelin (GHRP-2) and GHRP-6, but similarly to growth hormone-releasing hormone (GHRH), ipamorelin does not stimulate the secretion of adrenocorticotropic hormone (ACTH) or cortisol, and is highly selective for inducing the secretion only of GH.〔
Ipamorelin was originally developed by Novo Nordisk, and was investigated in phase II clinical trials by Helsinn Therapeutics for the treatment of ], but was discontinued due to lack of efficacy.〔(【引用サイトリンク】 Ipamorelin )
==See also==

* Anamorelin
* Capromorelin
* Examorelin (hexarelin)
* GHRP-6 (SKF-110679)
* Ibutamoren (MK-677)
* Macimorelin
* Pralmorelin (GHRP-2)
* Relamorelin
* SM-130,686
* Tabimorelin

抄文引用元・出典: フリー百科事典『 ウィキペディア(Wikipedia)
ウィキペディアで「Ipamorelin」の詳細全文を読む



スポンサード リンク
翻訳と辞書 : 翻訳のためのインターネットリソース

Copyright(C) kotoba.ne.jp 1997-2016. All Rights Reserved.